PMID- 24244017 OWN - NLM STAT- MEDLINE DCOM- 20140218 LR - 20211203 IS - 1550-6606 (Electronic) IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 191 IP - 12 DP - 2013 Dec 15 TI - Optineurin insufficiency impairs IRF3 but not NF-kappaB activation in immune cells. PG - 6231-40 LID - 10.4049/jimmunol.1301696 [doi] AB - Optineurin is a widely expressed polyubiquitin-binding protein that has been implicated in regulating cell signaling via its NF-kappaB essential modulator-homologous C-terminal ubiquitin (Ub)-binding region. Its functions are controversial, with in vitro studies finding that optineurin suppressed TNF-mediated NF-kappaB activation and virus-induced activation of IFN regulatory factor 3 (IRF3), whereas bone marrow-derived macrophages (BMDMs) from mice carrying an optineurin Ub-binding point mutation had normal TLR-mediated NF-kappaB activation and diminished IRF3 activation. We have generated a mouse model in which the entire Ub-binding C-terminal region is deleted (Optn(470T)). Akin to C-terminal optineurin mutations found in patients with certain neurodegenerative diseases, Optn(470T) was expressed at substantially lower levels than the native protein, allowing assessment not only of the lack of Ub binding, but also of protein insufficiency. Embryonic lethality with incomplete penetrance was observed for 129 x C57BL/6 Optn(470T/470T) mice, but after further backcrossing to C57BL/6, offspring viability was restored. Moreover, the mice that survived were indistinguishable from wild type littermates and had normal immune cell distributions. Activation of NF-kappaB in Optn(470T) BMDM and BM-derived dendritic cells with TNF or via TLR4, T cells via the TCR, and B cells with LPS or anti-CD40 was normal. In contrast, optineurin and/or its Ub-binding function was necessary for optimal TANK binding kinase 1 and IRF3 activation, and both Optn(470T) BMDMs and bone marrow-derived dendritic cells had diminished IFN-beta production upon LPS stimulation. Importantly, Optn(470T) mice produced less IFN-beta upon LPS challenge. Therefore, endogenous optineurin is dispensable for NF-kappaB activation but necessary for optimal IRF3 activation in immune cells. FAU - Munitic, Ivana AU - Munitic I AD - Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892. FAU - Giardino Torchia, Maria Letizia AU - Giardino Torchia ML FAU - Meena, Netra Pal AU - Meena NP FAU - Zhu, Guozhi AU - Zhu G FAU - Li, Caiyi C AU - Li CC FAU - Ashwell, Jonathan D AU - Ashwell JD LA - eng GR - Z01 BC010779-01/Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Intramural DEP - 20131115 PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Cell Cycle Proteins) RN - 0 (Eye Proteins) RN - 0 (Interferon Regulatory Factor-3) RN - 0 (Irf3 protein, mouse) RN - 0 (Lipopolysaccharides) RN - 0 (Membrane Transport Proteins) RN - 0 (NF-kappa B) RN - 0 (Optn protein, mouse) RN - 0 (Receptors, Antigen, B-Cell) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - 77238-31-4 (Interferon-beta) RN - EC 2.7.1.- (Tbk1 protein, mouse) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) SB - IM MH - Animals MH - Cell Cycle Proteins MH - Chimera MH - Crosses, Genetic MH - Dendritic Cells/immunology MH - Eye Proteins/genetics/*physiology MH - Gene Expression Regulation/immunology MH - Genes, Lethal MH - HEK293 Cells MH - Humans MH - Immunity, Innate MH - Interferon Regulatory Factor-3/*metabolism MH - Interferon-beta/biosynthesis/genetics MH - Lipopolysaccharides/pharmacology MH - Lymphocyte Subsets/immunology/*metabolism MH - Macrophages/immunology/*metabolism MH - Male MH - Membrane Transport Proteins MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - NF-kappa B/*metabolism MH - Phosphorylation MH - Protein Processing, Post-Translational MH - Protein Serine-Threonine Kinases/metabolism MH - Protein Structure, Tertiary MH - Receptors, Antigen, B-Cell/immunology MH - Sequence Deletion MH - Signal Transduction MH - Toll-Like Receptor 4/immunology MH - Tumor Necrosis Factor-alpha/pharmacology MH - Ubiquitination PMC - PMC3886234 MID - NIHMS531757 EDAT- 2013/11/19 06:00 MHDA- 2014/02/19 06:00 PMCR- 2014/12/15 CRDT- 2013/11/19 06:00 PHST- 2013/11/19 06:00 [entrez] PHST- 2013/11/19 06:00 [pubmed] PHST- 2014/02/19 06:00 [medline] PHST- 2014/12/15 00:00 [pmc-release] AID - jimmunol.1301696 [pii] AID - 10.4049/jimmunol.1301696 [doi] PST - ppublish SO - J Immunol. 2013 Dec 15;191(12):6231-40. doi: 10.4049/jimmunol.1301696. Epub 2013 Nov 15.